CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

BACKGROUND: Accumulating evidence suggests that the balance between pathogenic effector T cells (Teffs) and regulatory T cells (Tregs) may be important for controlling atherosclerotic disease. We hypothesized that a combination therapy with anti‐CD3 antibody (CD3‐Ab) and IL‐2/anti‐IL‐2 monoclonal an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kasahara, Kazuyuki, Sasaki, Naoto, Yamashita, Tomoya, Kita, Tomoyuki, Yodoi, Keiko, Sasaki, Yoshihiro, Takeda, Masafumi, Hirata, Ken‐ichi
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187475/
https://ncbi.nlm.nih.gov/pubmed/24755152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados